+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Keratitis Drug"

From
Herpes Keratitis - Pipeline Insight, 2024 - Product Thumbnail Image

Herpes Keratitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Acanthamoeba Keratitis - Pipeline Insight, 2024 - Product Thumbnail Image

Acanthamoeba Keratitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Neurotrophic Keratitis - Pipeline Insight, 2024 - Product Thumbnail Image

Neurotrophic Keratitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Severe Keratitis - Pipeline Insight, 2024 - Product Thumbnail Image

Severe Keratitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Severe Keratitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Severe Keratitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Herpes Keratitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Herpes Keratitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Keratitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Keratitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 90 Pages
  • Global
From
From
From
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Keratitis is an inflammation of the cornea, the clear outer layer of the eye. It is caused by a variety of infectious agents, including bacteria, viruses, fungi, and parasites. Infectious Diseases Drugs are used to treat keratitis, and the Keratitis Drug market is a subset of the larger Infectious Diseases Drugs market. Keratitis Drugs are typically administered topically, either as eye drops or ointments. They are designed to reduce inflammation, reduce pain, and eliminate the infectious agent. Commonly used drugs include antibiotics, antivirals, antifungals, and antiparasitics. The Keratitis Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Allergan, Bausch + Lomb, Merck, Pfizer, and Novartis. Show Less Read more